Future studies are also required to explore the effects of nicotinic acetylcholine receptor antibodies and siRNA on the proliferation, development, and invasion of lung cancer cells, so as to target α7 nAChR in treating lung cancer. Here, CHRNA7 is linked to lung carcinoma.